Silverarc Capital Management »

Kalvista Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.3M 759k 9.63
2023-06-30 $6.5M 721k 9.00
2023-03-31 $5.7M 724k 7.86
2021-06-30 $357k 15k 23.99
2021-03-31 $1.3M 50k 25.70

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Tang Capital Management
Vanguard Group
Boxer Capital
Caption Management
Citadel Advisors
Dimensional Fund Advisors
DAFNA Capital Management
Goldman Sachs Group
Rosalind Advisors
Citigroup
Two Sigma Advisers
Two Sigma Investments
Opaleye Management

View all funds holding Kalvista Pharmaceuticals